Patent intelligence · US
US 6524568
Enriched platelet wound healant
Enriched platelet wound healant
Patent details — US 6524568
- Jurisdiction
- US
- Status
- expired
- Grant date
- Feb 25, 2003
- Expiration
- Feb 20, 2023
- Applicant
- Cytomedix, Inc.
- Claims
- 25
- CPC classes
- A61K, A61K31/00, A61K35/19, A61K38/4833
Quick answer
US 6524568 (Enriched platelet wound healant) is held by Cytomedix, Inc.. Status: expired. Granted Feb 25, 2003. Expires Feb 20, 2023 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Cytomedix, Inc.
- Grant date
- Expiration
- Claims
- 25
- CPC classes
- A61K, A61K31/00, A61K35/19, A61K38/4833
More from Cytomedix, Inc.
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 6524568?
US 6524568 (Enriched platelet wound healant) is held by Cytomedix, Inc.. Status: expired. Granted Feb 25, 2003. Expires Feb 20, 2023 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6524568?
Cytomedix, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 3 pharmaceutical patents for this assignee.
When does US 6524568 expire?
Our index shows an expiration date of Feb 20, 2023 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.